[
    [
        {
            "time": "",
            "original_text": "医药股在香港集体爆发 行业多重利好催化审评审批效率提速",
            "features": {
                "keywords": [
                    "医药股",
                    "香港",
                    "爆发",
                    "多重利好",
                    "审评审批",
                    "效率提速"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药股在香港集体爆发 行业多重利好催化审评审批效率提速",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "2021年医药行业政策系列：MAH(药品上市许可持有人)制度红利释放 引燃医药产业创新热情",
            "features": {
                "keywords": [
                    "2021年",
                    "医药行业",
                    "政策",
                    "MAH制度",
                    "红利释放",
                    "创新热情"
                ],
                "sentiment_score": 0.85,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "2021年医药行业政策系列：MAH(药品上市许可持有人)制度红利释放 引燃医药产业创新热情",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 7,
                "Duration": 9,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 4
            }
        },
        {
            "time": "",
            "original_text": "中泰证券：药品审评审批“速”“质”提升，全面利好医药行业发展",
            "features": {
                "keywords": [
                    "中泰证券",
                    "药品审评审批",
                    "速度",
                    "质量",
                    "提升",
                    "全面利好",
                    "医药行业"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "中泰证券：药品审评审批“速”“质”提升，全面利好医药行业发展",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        }
    ]
]